MEDITOPE BIOSCIENCES
Meditope Biosciences, Inc., a biotechnology company, develops antibody based cancer therapeutics. The company was founded in 2011 and is based in Pasadena, California.
MEDITOPE BIOSCIENCES
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2011-01-01
Address:
Pasadena, California, United States
Country:
United States
Website Url:
http://www.meditope.com
Total Employee:
11+
Status:
Active
Contact:
6267933631
Email Addresses:
[email protected]
Total Funding:
3.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Google Google Cloud Sectigo SSL
Similar Organizations
1st Human Therapeutics
1st Human Therapeutics is a biotechnology company focused on developing first-in-human therapeutics.
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Alethia BioTherapeutics
Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Arius Research
ARIUS Research is a biotechnology company developing antibody therapeutics.
Carmenta Bioscience
Carmenta Bioscience is a technology company focused on improving maternal and fetal health.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
iZumi Bio
IZumi Bio, a biotechnology company, employs cellular reprograming for the development of stem cell-based therapeutics.
MabSpace Biosciences
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
Magen BioSciences
Magen BioSciences is a Biotechnology company located in 100 Beaver Street, Suite 101, Waltham, MA, United States.
Neoantigenics
Neoantigenics is a liability company that focuses on developing oncology theranostics.
Neurovation Labs
Neurovation Labs is a biotech company focused CNS disorders, starting first with Post-traumatic Stress Disorder (PTSD).
Raze Therapeutics
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
Rebirthel
Rebirthel is a biotech company, focused on the Development and operationalization of cell-based cancer immunotherapies.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Spear Bio
Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.
SynerGene Therapeutics
SynerGene Therapeutics is a biotechnology company with focuses on developing gene-based nanotech cancer therapeutics and diagnostics.
Current Employees Featured
Founder
Official Site Inspections
http://www.meditope.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Meditope Biosciences"
Home | MEDITOPE BIOSCIENCES
Driven by a spirit of creativity and collaboration, we are catalyzing innovation in areas of the gravest unmet medical needs with a focus and dedication to developing the next generation of …See details»
What is a Meditope? - MEDITOPE BIOSCIENCES
Residing in the 'middle place' of the antibody's Fab region, the term “meditope” was born – derived from the Latin "medius" for middle and Greek "topos" for place. Learn more about Meditope's unique technology platform discovered at …See details»
Our Team - MEDITOPE BIOSCIENCES
Drawn by a passion for SnAP technology and all the innovative potential that it represents, our team represents an impressive and remarkable blend of breadth and depth of experience.See details»
What is a Meditope? An avenue to combat cancer?
Jun 23, 2014 · Researchers at City of Hope, led by John, Williams, Ph.D., have hit upon a revolutionary avenue to combat cancer -- and potentially many other diseases. It's...See details»
Meditope Biosciences - Crunchbase Company Profile & Funding
Meditope Biosciences, Inc., a biotechnology company, develops antibody based cancer therapeutics. The company was founded in 2011 and is based in Pasadena, California. A …See details»
Meditope Biosciences Company Profile 2024: …
Information on valuation, funding, cap tables, investors, and executives for Meditope Biosciences.See details»
Martin Latterich - President, CEO, Director at Meditope ... - The Org
President, CEO, Director at Meditope Biosciences Contact Dr. Latterich is a biotechnology executive with a strong mix of corporate leadership and academic experience.See details»
Meditope Biosciences - Funding, Financials, Valuation & Investors
Meditope Biosciences is a biotechnology company focused on developing antibody-based cancer therapeutics.See details»
Meditope Biosciences - Contacts, Employees, Board Members
Meditope Biosciences is a biotechnology company focused on developing antibody-based cancer therapeutics.See details»
Meditope Biosciences - VentureRadar
Website: http://www.meditope.com Develops SnAP technology, transforming monoclonal antibodies into a modular system for consistent and controllable attachment, enabling limitless …See details»
Development of a High Affinity, Non-covalent Biologic to Add ...
Jan 15, 2015 · Recently, we engineered a binding site for a peptide named “meditope” within the Fab of trastuzumab. Proximity of the meditope site to that of protein L suggested an …See details»
Mechanically interlocked functionalization of monoclonal antibodies
Apr 20, 2018 · Meditope-Fab is a peptide-antibody complex potentially useful for drug delivery and diagnostic, but a short half-life prevents its use in vivo.See details»
Partnering | MEDITOPE BIOSCIENCES
Meditope Biosciences is actively seeking strategic partnerships to discover and develop next generation antibody therapies. These partnerships will allow us to not only expand the …See details»
Efficacy of photoactivated generation of a meditope-enabled anti …
May 20, 2016 · This novel binding is exploited for site-specific covalent conjugation of cytotoxic payloads to any meditope-enabled antibody. The meditope peptide can be designed with a …See details»
Meditopia: Meditope-Enabled Bonds and their Affinity …
May 13, 2022 · We centered on four mutations that can increase the affinity between the meditope and the mAb, allowing for a stronger bond. Our focus was on the anti-epidermal growth factor receptor mAb cetuximab, which tracks the …See details»
Cyclization strategies of meditopes: affinity and diffraction studies ...
Jun 1, 2016 · Apo cetuximab Fab and complexes with meditope variants were crystallized by the hanging-drop vapor-diffusion method. In a typical experiment, the Fab was mixed with excess …See details»
Affinity Maturation of a Cyclic Peptide Handle for Therapeutic ...
Here we show that the affinity of a recently reported meditope for cetuximab can be substantially enhanced using a combination of yeast display and deep mutational scanning.See details»
Meditope–Fab interaction: threading the hole - PMC
Dec 12, 2017 · Our recent discovery of meditope, a cyclic peptide that binds to a Fab cavity of cetuximab, can serve as an alternative, noncovalent method to modify antibodies, with a …See details»
(IUCr) Cyclization strategies of meditopes: affinity and diffraction ...
Apr 27, 2016 · In order to better understand the interactions that drive this unique complex, a number of variants including the residues within the meditope peptide and the antibody, as …See details»
Meditope–Fab interaction: threading the hole - International …
Nov 10, 2017 · Our recent discovery of meditope, a cyclic peptide that binds to a Fab cavity of cetuximab, can serve as an alternative, noncovalent method to modify antibodies, with a …See details»